Cue Biopharma, Inc. (CUE) NASDAQ
0.57
-0.0065(-1.12%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.57
-0.0065(-1.12%)
Currency In USD
| Market Cap | 28.93M |
| Enterprise Value | 5.99M |
| P/E Ratio | -2.33 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 1.65 |
| Price/Book Ratio | 2.34 |
| Enterprise/Revenue | 0.81 |
| Enterprise/EBITDA | -0.97 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.97 |
| Operating Margin | -0.97 |
| Return On Assets | -0.63 |
| Return On Equity | -1.65 |
| Revenue | 27.47M |
| Revenue/Share | 0.25 |
| Gross Profit | 23.99M |
| EBITDA | -23.04M |
| Net Income | -26.6M |
| Diluted EPS | -0.28 |
| Total Cash | 27.14M |
| Total Cash/Share | 0.25 |
| Total Debt | 4.2M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 2.74 |
| Book Value Per Share | 0.24 |
| 52-Week Change | -31.41 |
| 52-Week High | 1.03 |
| 52-Week Low | 0.17 |
| Moving Average 50 Days | 0.33 |
| Moving Average 200 Days | 0.56 |
| Average Volume | 9.4M |
| Shares Outstanding | 78.84M |
| % Held by Institutions | 21.6 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | April 24, 2026 |